1,2-dimethylhydrazine multiple interactions ISO RGD:731797 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHYH mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:731797 6480464 1, 2-Dimethylhydrazine results in decreased expression of PHYH mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:731797 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHYH mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of PHYH mRNA CTD PMID:15953391 more ... 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PHYH mRNA CTD PMID:26496021 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PHYH protein CTD PMID:32145629 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731797 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHYH mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PHYH mRNA CTD PMID:34747641 2-acetamidofluorene multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of PHYH mRNA, [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of PHYH mRNA CTD PMID:14656948 , PMID:16158176 2-methylcholine affects expression ISO RGD:731796 6480464 beta-methylcholine affects the expression of PHYH mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:731797 6480464 3 more ... CTD PMID:19467301 5-aza-2'-deoxycytidine affects expression ISO RGD:731796 6480464 Decitabine affects the expression of PHYH mRNA CTD PMID:23300844 5-fluorouracil affects response to substance ISO RGD:731796 6480464 PHYH protein affects the susceptibility to Fluorouracil CTD PMID:16217747 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of PHYH mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of PHYH mRNA CTD PMID:19483382 acetamide affects expression EXP 6480464 acetamide affects the expression of PHYH mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of PHYH mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO RGD:731796 6480464 Aflatoxin B1 results in decreased expression of PHYH mRNA CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:731796 6480464 Tretinoin results in decreased expression of PHYH mRNA CTD PMID:33167477 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of PHYH mRNA CTD PMID:19483382 amitriptyline increases expression ISO RGD:731796 6480464 Amitriptyline results in increased expression of PHYH mRNA CTD PMID:15342952 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PHYH mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:731796 6480464 Antirheumatic Agents results in increased expression of PHYH mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:731796 6480464 aristolochic acid I results in increased expression of PHYH mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:731797 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of PHYH mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:731796 6480464 Arsenic affects the methylation of PHYH gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:731796 6480464 Arsenic affects the methylation of PHYH gene CTD PMID:25304211 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of PHYH mRNA CTD PMID:19483382 bis(2-chloroethyl) sulfide increases expression ISO RGD:731797 6480464 Mustard Gas results in increased expression of PHYH mRNA CTD PMID:15674844 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PHYH mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:731796 6480464 bisphenol A results in increased expression of PHYH mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PHYH mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:731796 6480464 bisphenol A affects the expression of PHYH mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PHYH mRNA, bisphenol A results in decreased expression of PHYH protein CTD PMID:30816183 , PMID:32145629 chlorpromazine increases expression ISO RGD:731796 6480464 Chlorpromazine results in increased expression of PHYH mRNA CTD PMID:15342952 chlorpyrifos decreases expression ISO RGD:731797 6480464 Chlorpyrifos results in decreased expression of PHYH mRNA CTD PMID:37019170 chromium(6+) affects expression ISO RGD:731797 6480464 chromium hexavalent ion affects the expression of PHYH mRNA CTD PMID:28472532 cisplatin affects expression ISO RGD:731796 6480464 Cisplatin affects the expression of PHYH mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:731796 6480464 Cisplatin results in increased expression of PHYH mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:731796 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PHYH mRNA CTD PMID:27392435 clarithromycin decreases expression ISO RGD:731796 6480464 Clarithromycin results in decreased expression of PHYH mRNA CTD PMID:15342952 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of PHYH mRNA CTD PMID:19483382 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of PHYH mRNA CTD PMID:17602206 clomipramine increases expression ISO RGD:731796 6480464 Clomipramine results in increased expression of PHYH mRNA CTD PMID:15342952 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PHYH mRNA CTD PMID:24386269 copper(II) sulfate decreases expression ISO RGD:731796 6480464 Copper Sulfate results in decreased expression of PHYH mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:731797 6480464 Asbestos, Crocidolite results in decreased expression of PHYH mRNA CTD PMID:29279043 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of PHYH mRNA CTD PMID:18539377 cyclosporin A decreases expression ISO RGD:731796 6480464 Cyclosporine results in decreased expression of PHYH mRNA CTD PMID:20106945 , PMID:25562108 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PHYH mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:731797 6480464 Dibutyl Phthalate results in decreased expression of PHYH mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:731796 6480464 dicrotophos results in decreased expression of PHYH mRNA CTD PMID:28302478 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PHYH mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:731796 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:731796 6480464 Doxorubicin affects the expression of PHYH mRNA CTD PMID:25529476 doxorubicin decreases expression ISO RGD:731796 6480464 Doxorubicin results in decreased expression of PHYH mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PHYH mRNA CTD PMID:29391264 ethanol affects expression ISO RGD:731797 6480464 Ethanol affects the expression of PHYH mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:731796 6480464 Ethyl Methanesulfonate results in increased expression of PHYH mRNA CTD PMID:23649840 fenamidone increases expression ISO RGD:731797 6480464 fenamidone results in increased expression of PHYH mRNA CTD PMID:27029645 folic acid multiple interactions ISO RGD:731797 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHYH mRNA CTD PMID:22206623 indometacin affects expression EXP 6480464 Indomethacin affects the expression of PHYH mRNA CTD PMID:36868495 ivermectin decreases expression ISO RGD:731796 6480464 Ivermectin results in decreased expression of PHYH protein CTD PMID:32959892 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of PHYH mRNA CTD PMID:19483382 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PHYH mRNA CTD PMID:30467583 methotrexate increases expression ISO RGD:731796 6480464 Methotrexate results in increased expression of PHYH mRNA CTD PMID:17400583 methyl methanesulfonate increases expression ISO RGD:731796 6480464 Methyl Methanesulfonate results in increased expression of PHYH mRNA CTD PMID:23649840 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of PHYH mRNA CTD PMID:21515302 N-nitrosodiethylamine multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of PHYH mRNA, [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of PHYH mRNA CTD PMID:14656948 , PMID:16158176 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of PHYH mRNA CTD PMID:22110744 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of PHYH mRNA CTD PMID:33484710 ofloxacin decreases expression ISO RGD:731796 6480464 Ofloxacin results in decreased expression of PHYH mRNA CTD PMID:15342952 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of PHYH mRNA CTD PMID:19483382 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PHYH mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:731797 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PHYH mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:731796 6480464 Acetaminophen results in increased expression of PHYH mRNA CTD PMID:15342952 paracetamol affects expression ISO RGD:731797 6480464 Acetaminophen affects the expression of PHYH mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of PHYH mRNA CTD PMID:32680482 perfluorooctanoic acid decreases expression ISO RGD:731797 6480464 perfluorooctanoic acid results in decreased expression of PHYH mRNA CTD PMID:17681415 phenylmercury acetate multiple interactions ISO RGD:731796 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHYH mRNA CTD PMID:27188386 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of PHYH mRNA CTD PMID:19483382 progesterone increases expression EXP 6480464 Progesterone results in increased expression of PHYH mRNA CTD PMID:20726854 Propiverine affects binding EXP 6480464 propiverine binds to PHYH protein CTD PMID:29273565 resveratrol multiple interactions ISO RGD:731797 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of PHYH mRNA] CTD PMID:31298478 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PHYH protein CTD PMID:35544339 SB 431542 multiple interactions ISO RGD:731796 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sertraline increases expression ISO RGD:731796 6480464 Sertraline results in increased expression of PHYH mRNA CTD PMID:15342952 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PHYH protein CTD PMID:29459688 sotalol increases expression ISO RGD:731796 6480464 Sotalol results in increased expression of PHYH mRNA CTD PMID:17567588 sulfamethoxazole decreases expression ISO RGD:731796 6480464 Sulfamethoxazole results in decreased expression of PHYH mRNA CTD PMID:15342952 sulforaphane increases expression ISO RGD:731797 6480464 sulforaphane results in increased expression of PHYH mRNA CTD PMID:30529165 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of PHYH mRNA CTD PMID:15885361 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of PHYH mRNA CTD PMID:21515302 testosterone decreases expression ISO RGD:731797 6480464 Testosterone results in decreased expression of PHYH mRNA CTD PMID:19693291 tetrachloromethane decreases expression ISO RGD:731797 6480464 Carbon Tetrachloride results in decreased expression of PHYH mRNA CTD PMID:31919559 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of PHYH mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PHYH mRNA CTD PMID:34492290 thioridazine increases expression ISO RGD:731796 6480464 Thioridazine results in increased expression of PHYH mRNA CTD PMID:15342952 titanium dioxide multiple interactions ISO RGD:731797 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of PHYH mRNA] CTD PMID:31298478 titanium dioxide decreases expression ISO RGD:731797 6480464 titanium dioxide results in decreased expression of PHYH mRNA CTD PMID:31298478 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PHYH mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:731796 6480464 trichostatin A results in decreased expression of PHYH mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:731796 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHYH mRNA CTD PMID:27188386 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of PHYH mRNA CTD PMID:21515302 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of PHYH mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:731796 6480464 Valproic Acid results in decreased expression of PHYH mRNA CTD PMID:29154799 , PMID:29501571 valproic acid decreases methylation ISO RGD:731796 6480464 Valproic Acid results in decreased methylation of PHYH gene CTD PMID:29501571 valproic acid affects expression ISO RGD:731796 6480464 Valproic Acid affects the expression of PHYH mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:731796 6480464 Valproic Acid results in increased methylation of PHYH gene CTD PMID:29154799 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of PHYH mRNA CTD PMID:12672911 , PMID:15671213 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of PHYH mRNA CTD PMID:12672911 , PMID:15671213